Safer use of antipsychotics in youth (SUAY) pragmatic trial protocol

• DOI: 10.1016/j.cct.2020.106184
• Publication Date: 2020-10-20T05:26:23Z
• Authors: Robert B. Penfold; Ella E. Thompson; Robert J. Hilt; Kelly J. Kelleher; Nadine Schwartz; Arne Beck; Gregory N. Clarke; James D. Ralston; Andrea L. Hartzler; R. Yates Coley; Mary Akosile; Benedetto Vitiello; Gregory E. Simon
• Keywords: Washington; 03 medical and health sciences; 0302 clinical medicine; Adolescent; Adolescents; Antipsychotic; Children; Psychiatry consults; Humans; Child; Referral and Consultation; Antipsychotic Agents; Randomized Controlled Trials as Topic; 3. Good health

Programs such as the Pediatric Access Line in Washington state have shown decreases in antipsychotic medication use by youth with non-psychotic disorders. Program outcomes have been studied with observational designs. This manuscript describes the protocol for Targeted and Safer Use of Antipsychotics in Youth (SUAY), a randomized controlled trial of psychiatrist review of prescriptions and facilitated access to psychosocial care. The aim of the intervention is to reduce the number of person-days of antipsychotic use among participants.Recruitment occurs at 4 health systems. Targeted enrollment is 800 youth aged 3-17 years. Clinicians are block randomized to intervention versus usual care prior to the study. Youth are nested within the arm of the prescribing clinician. Clinicians in the intervention group receive an EHR-based best practice alert with options to expedite access to psychosocial care and all medication orders are reviewed by a child and adolescent psychiatrist with feedback provided to the prescriber. The primary outcome is person-days of antipsychotic medication use in the 6 months following the initial order. All randomized individuals contribute data regardless of their level of participation (including declining all services).The trial has been approved by the institutional review boards at each of the 4 sites. The intervention has 4 novel design features including automated recruitment using a best practice alert, psychiatrist medication order review and consultation, telephone navigation to psychosocial care, and telemental health visits. Recruitment began in March of 2018 and will be completed in June 2020. Follow-up will be completed December 31, 2020.Clinicaltrials.gov, NCT03448575.